DOI: https://dx.doi.org/10.18203/2349-3291.ijcp20222427
Published: 2022-09-26

Thanatophoric dysplasia: a case report at Federal Medical Centre Yenagoa, Bayelsa state Nigeria

Okemena O. Onotume, Urire Idholo, Immaculata I. Tunde-Oremodu, Ofure Okosun, Oyedeji O. Adeyemi, Onyaye Kunle-Olowu

Abstract


Thanatophoric dysplasia is a rare congenital severe skeletal disorder previously considered lethal but some survivals beyond the neonatal period have been reported due to extensive medical interventions. There have been a few studies on thanatophoric dysplasia in Africa and specifically in Nigeria hence this case report of an 8-day old female who was born with clinical features that were consistent with thanatophoric dysplasia creating awareness in this region. An eight-day old female term neonate who was seen in the special care baby unit with respiratory distress and limb abnormalities from birth. Two obstetric ultrasound scans had revealed a fetus with severe limb deformity. At presentation, she was in respiratory distress, with dysmorphic features, small chest wall with chest hypertelorism. The limbs were short having marks of amniotic bands with lymphoedema affecting both lower limbs. There were no palmar creases. Skeletal survey done revealed marked hypoplasia of the chest cavity, and widening of both proximal and distal epiphyses of all long bones showing telephone receiving appearance. Echocardiography and abdominal ultrasound scans were normal. It was documented that thanatophoric dysplasia was inherited in an autosomal dominant fashion however sporadic mutations do occur as seen in this patient who had no family history. Facility for genetic testing to analyse the fibroblast growth factor receptor (FGFR3) for typing and determining possible mutations was not available to confirm the diagnosis however, her clinical features and radiological findings were suggestive of thanotophoric dysplasia type 1.


Keywords


Thanatophoric dysplasia, Fibroblast growth factor, Jeune syndrome

Full Text:

PDF

References


NIH. Fact sheet: Thanatophoric dysplasia. Available at: https://rarediseases.info.nih.gov/diseases/85/thanatophoric-dysplasia. Accessed 15 June 2022.

Carroll SR, Duker AL, Schelhaas AJ, Little EM, Miller EG, Bober MB. Should we stop calling thanatophoric dysplasia a lethal condition? A case report of a long-term survivor. Palliat Med Rep. 2020;1(1):32-9.

Donnelly DE, McConnell V, Paterson A, Morrison PJ. The prevalence of thanatophoric dysplasia and lethal osteogenesis imperfecta type II in Northern Ireland-a complete population study. Ulster Med J. 2010;79(3):114-8.

Joel-Medewase V, Aworinde O, Alabi A, Lekan-Kehinde O. Lethal Neonatal rhizomelic dwarfism: a report of two cases. Int J Health Sci Res. 2018;8(12):178-83.

Komolafe F, Adetoro OO. Thanatophoric dwarfism in a Nigerian Child. Afr J Med Med Sci. 1986;15(3-4):109-12.

Daniyan OW, Ezeanosike OB, Ogbonna-Nwosu C, Iloduba UC. Thanatophoric dysplasia type 1 as seen in a tertiary institution in South-East Nigeria: A case report. Niger J Pediatr. 2020;47:277-9.

Maroteux P, Lamy M, Robbert JM. Lenanismethanatophore. La Presse Medicale. 1967:2519-24.